Haiquan Lu

3.5k total citations · 4 hit papers
52 papers, 2.7k citations indexed

About

Haiquan Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Haiquan Lu has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Haiquan Lu's work include Cancer, Hypoxia, and Metabolism (17 papers), Epigenetics and DNA Methylation (8 papers) and RNA modifications and cancer (7 papers). Haiquan Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Epigenetics and DNA Methylation (8 papers) and RNA modifications and cancer (7 papers). Haiquan Lu collaborates with scholars based in United States, China and Japan. Haiquan Lu's co-authors include Gregg L. Semenza, Debangshu Samanta, Ivan Chen, Chuanzhao Zhang, John W. Bullen, Huimin Zhang, Xiaoshun He, Lisha Xiang, Daniele M. Gilkes and Zhen Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Haiquan Lu

50 papers receiving 2.7k citations

Hit Papers

Hypoxia induces the breast cancer stem cell phenotype by ... 2015 2026 2018 2022 2016 2015 2015 2016 250 500 750

Peers

Haiquan Lu
Debangshu Samanta United States
Giulia Biffi United Kingdom
Dan Liao China
Hariharan Easwaran United States
László Perlaky United States
Debangshu Samanta United States
Haiquan Lu
Citations per year, relative to Haiquan Lu Haiquan Lu (= 1×) peers Debangshu Samanta

Countries citing papers authored by Haiquan Lu

Since Specialization
Citations

This map shows the geographic impact of Haiquan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiquan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiquan Lu more than expected).

Fields of papers citing papers by Haiquan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiquan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiquan Lu. The network helps show where Haiquan Lu may publish in the future.

Co-authorship network of co-authors of Haiquan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Haiquan Lu. A scholar is included among the top collaborators of Haiquan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiquan Lu. Haiquan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Haiquan & Zhiang Wu. (2025). Revisiting intelligent audit from a data science perspective. Neurocomputing. 623. 129431–129431. 7 indexed citations
3.
Tang, Yanhui, Peng Zhu, Haiquan Lu, et al.. (2023). The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia. Annals of Hematology. 103(9). 3385–3398. 4 indexed citations
4.
5.
Liu, Jia, Jie Lan, Zhao-Xue Yu, et al.. (2023). Targeting hypoxia-induced CBS expression inhibits breast cancer stem cells through the induction of ferroptosis. Genes & Diseases. 10(6). 2195–2198. 1 indexed citations
6.
Yang, Yongkang, Qiaozhu Zuo, Haiquan Lu, et al.. (2022). NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science Advances. 8(49). eabo5000–eabo5000. 20 indexed citations
7.
Yang, Yongkang, et al.. (2022). HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia. Nature Communications. 13(1). 316–316. 65 indexed citations
8.
Liu, Jing, Yan Zeng, Jing Guo, et al.. (2022). Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia. Frontiers in Immunology. 13. 1038570–1038570. 8 indexed citations
9.
Wang, Zheng, et al.. (2022). Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma. Frontiers in Pharmacology. 13. 972934–972934. 5 indexed citations
10.
Wang, Yufeng, Kangsheng Tu, Qiuran Xu, et al.. (2021). Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Science Advances. 7(35). 62 indexed citations
11.
Lu, Haiquan, Yangyiran Xie, Thi My Linh Tran, et al.. (2020). Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. Journal of Clinical Investigation. 130(9). 4607–4623. 86 indexed citations
12.
Lu, Haiquan, Yang Lü, Yangyiran Xie, et al.. (2019). Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma. JCI Insight. 4(19). 22 indexed citations
13.
Lu, Haiquan, Thi My Linh Tran, Youngrok Park, et al.. (2018). Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment. Cancer Research. 78(15). 4191–4202. 72 indexed citations
14.
Lu, Haiquan, Ivan Chen, Larissa A. Shimoda, et al.. (2017). Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment. Cell Reports. 18(8). 1946–1957. 133 indexed citations
15.
Lu, Haiquan, Xinqun Li, Yang Lü, Songbo Qiu, & Zhen Fan. (2016). ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis. Cancer Letters. 381(1). 23–30. 54 indexed citations
16.
Lu, Haiquan, Xinqun Li, Zhongguang Luo, Jie Liu, & Zhen Fan. (2013). Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A. Molecular Cancer Therapeutics. 12(10). 2187–2199. 69 indexed citations
18.
Li, Xinqun, et al.. (2010). 1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy. PLoS ONE. 5(12). e15823–e15823. 14 indexed citations
19.
Butler, E. Brian, Arnold C. Paulino, Haiquan Lu, et al.. (2007). Computer Visualization Techniques (CVTs) Foster Evidence-Based Target Delineation. Cancer Investigation. 25(1). 1–5. 7 indexed citations
20.
Lu, Haiquan, Zheng Gong, & Tian-Shu Cao. (1990). Studies on the genomic coding assignments of rice ragged stunt virus.. 6(2). 167–172. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026